The FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines. As of August 23, 2021, the FDA has issued full approval of the Pfizer-BioNTech vaccine for use with individuals ages 16 and over, and as of January 31, 2022 has issued full approval for the Moderna vaccine for use in individuals ages 18 and over.
The previously issued Emergency Use Authorizations (EUA) for COVID-19 vaccines manufactured by Pfizer-BioNTech (for ages 6 months to 15 years), Moderna (for ages 6 months to 17 years) and Johnson & Johnson’s Janssen remain in effect. An EUA gives the FDA authority to allow unapproved medical products to be used in emergencies when no approved alternatives are available. Other COVID-19 vaccines are in development and will be reviewed by the FDA under EUA. Find the current status of the vaccine approvals and EUAs.